Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Prednisolone
Drug ID BADD_D01831
Description Prednisolone is a glucocorticoid similar to [cortisol] used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.[A187463] Prednisolone was granted FDA approval on 21 June 1955.[L9431]
Indications and Usage Prednisolone is indicated to treat endocrine, rheumatic, and hematologic disorders; collagen, dermatologic, ophthalmic, respiratory, and gastrointestinal diseases; allergic and edematous states; and other conditions like tuberculous meningitis.[L9542]
Marketing Status approved; vet_approved
ATC Code A01AC04; A07EA01; C05AA04; D07AA03; D07XA02; H02AB06; R01AD02; S01BA04; S01CB02; S02BA03; S03BA02
DrugBank ID DB00860
KEGG ID D00472
MeSH ID D011239
PubChem ID 5755
TTD Drug ID D0D1SG
NDC Product Code 38779-0150; 64958-0097; 82298-104; 67296-1656; 50383-042; 59651-491; 63187-466; 0527-5406; 65089-0038; 50090-0655; 57582-004; 62135-437; 73534-505; 49452-5980; 82298-105; 82298-106; 60592-911; 60722-3001; 51927-0234; 22552-0052
UNII 9PHQ9Y1OLM
Synonyms Prednisolone | Predate | Predonine | Di-Adreson-F | Di Adreson F | DiAdresonF
Chemical Information
Molecular Formula C21H28O5
CAS Registry Number 50-24-8
SMILES CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pain08.01.08.004--
Pain of skin23.03.03.0030.000035%
Palpitations02.11.04.0120.000437%
Pancreatitis07.18.01.001--
Pancreatitis haemorrhagic07.18.01.003--Not Available
Pancreatitis necrotising07.18.01.0040.000070%Not Available
Pancytopenia01.03.03.0030.000629%Not Available
Panic attack19.06.04.0010.000105%Not Available
Panniculitis23.07.02.002; 10.01.03.0240.000157%Not Available
Papilloedema24.03.07.001; 17.07.02.004; 06.09.02.0020.000070%
Papule23.03.03.0380.000122%Not Available
Paraesthesia23.03.03.094; 17.02.06.005--
Paralysis17.01.04.0040.000070%Not Available
Paranoia19.05.01.0050.000140%Not Available
Paraparesis17.01.04.0060.000105%Not Available
Paraplegia17.01.04.0070.000140%Not Available
Pathological fracture16.32.03.007; 15.08.02.008; 12.04.02.0060.000122%Not Available
Peliosis hepatis09.01.07.0100.000122%Not Available
Pemphigoid23.03.01.004; 10.04.02.0020.000052%Not Available
Pemphigus23.03.01.005; 10.04.02.0030.000210%Not Available
Peptic ulcer07.04.07.0010.000035%Not Available
Pericardial effusion02.06.01.0020.000122%
Pericardial haemorrhage24.07.01.013; 02.06.01.0030.000035%Not Available
Pericarditis02.06.02.0010.000070%
Peripheral sensory neuropathy17.09.03.0050.000035%
Personality change19.05.01.006; 17.02.05.0190.000105%
Personality disorder19.05.02.0020.000035%Not Available
Petechiae24.07.06.004; 23.06.01.003; 01.01.03.0020.000217%Not Available
Pharyngeal oedema22.04.05.003; 10.01.05.016; 23.04.01.0160.000070%Not Available
Phlebitis24.12.03.004; 12.02.01.0020.000035%
The 16th Page    First    Pre   16 17 18 19 20    Next   Last    Total 36 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene